TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The aim of this study was to observe whether maintaining a high level of platelet count after TPO-RA in patients with primary immune thrombocytopenia (ITP) can induce immune tolerance, develop immune balance in ITP patients, and enable patients to achieve a sustained response (SRoT) after TPO-RA discontinuation.
Epistemonikos ID: 5a8a2bda74c0f75b5ace578f74b4caf2a635b7cc
First added on: Jul 01, 2024